HPTN Publications

Machekano R, McFarland W, Mbizvo MT, Bassett MT, Katzenstein D, Latif AS . Impact of HIV counselling and testing on HIV seroconversion and reported STD incidence among male factory workers in Harare, Zimbabwe. Central Af J Med. 1998, 44: 98-102

Machekano RN, Bassett MT, Zhou PS, Mbizvo MT, Latif AS, Katzenstein DA . Report of sexually transmitted diseases by HIV infected men during follow up: time to target the infected?. Sex Transm Infect. 2000, 76: 188-92

Macleod D, Shanaube K, Skalland T, Limbada M, Mandla N, Bwalya J, Schaap A, Yang B, Donnell D, Piwowar-Manning E, Eshleman SH, Hoddinott G, Bond V, Moore A, Griffith S, Bock P, Ayles H, Fidler S, Hayes R, Floyd S; HPTN 071 (PopART) Study Team. . Viral suppression and self-reported ART adherence after 3 years of universal testing and treatment in the HPTN 071 (PopART) community-randomised trial in Zambia and South Africa: a cross-sectional analysis. Lancet HIV. 2022, 9: e751-e759

MacPhail C, Khoza N, Selin A, Julien A, Twine R, Wagner RG, Gomez-Olive X, Kahn K, Wang J, Pettifor A . Cash transfers for HIV prevention: what do young women spend it on? Mixed methods findings from HPTN 068.. BMC Public Health. 2017, 18: 10

MacQueen K, Alleman P . International Perspectives on the Collection, Storage, and Testing of Human Biospecimens in HIV Research. IRB: Ethics and Human Research. 2008, 30: 9-14 PMID:18767319

MacQueen KM, Abdool Karim Q, Sugarman J . Ethics guidance for HIV prevention trials. BMJ. 2003, 327: 340

Macqueen KM, McLoughlin K, Alleman P, Burke HM, Mack N . Partnering for Care in HIV Prevention Trials. J Empir Res Hum Res Ethics. 2008, 3: 5-18 PMID:19385753

Macqueen KM, Namey E, Chilongozi DA, Mtweve SP, Mlingo M, Morar N, Reid C, Ristow A, Sahay S, HPTN 035 Standard of Care Assessment Team . Community perspectives on care options for HIV prevention trial participants. AIDS Care. 2007, 19: 554-60 PMID:17453597